Innoviva
INVA
116 hedge funds and large institutions have $1.19B invested in Innoviva in 2016 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 41 increasing their positions, 31 reducing their positions, and 14 closing their positions.
2,864% more call options, than puts
Call options by funds: $17.8M | Put options by funds: $601K
121% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 14
32% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 31
20% more capital invested
Capital invested by funds: $992M → $1.19B (+$200M)
17% more funds holding
Funds holding: 99 → 116 (+17)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
Top Sellers
| 1 |
CC
Clearline Capital
New York
|
-$16.8M |
| 2 |
AC
Armistice Capital
New York
|
-$12.3M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$9.06M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$6.84M |
| 5 |
GL
GLG LLC
New York
|
-$6.43M |
INVA Hedge Fund Activity: Q1 2016 in Review
116 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q1 2016, worth a combined $1.19B — up 20% from $992M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new INVA positions and 14 closed out — a net gain of 17 holders — while 41 added to existing stakes and 31 trimmed.
The largest buyer was First Eagle Investment Management, opening a new position worth an estimated $35.4M. The largest seller was Clearline Capital, exiting entirely with an estimated $16.8M sold.
- 116 institutional investors held Innoviva (INVA) as of Q1 2016, up from 99 in Q4 2015.
- Funds reported $1.19B of Innoviva stock for Q1 2016, up 20% quarter-over-quarter.
- 31 funds opened new Innoviva positions in Q1 2016 and 14 closed out, a net change of +17 holders.
- The largest Innoviva buyer in Q1 2016 was First Eagle Investment Management, an estimated $35.4M added.
- The largest Innoviva seller in Q1 2016 was Clearline Capital, an estimated $16.8M sold.
Based on aggregated 13F filings for Q1 2016.